Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Astria Therapeutics, Inc. | a2224803zs-1a.htm |
| EX-10.7 - EX-10.7 - Astria Therapeutics, Inc. | a2224803zex-10_7.htm |
| EX-10.8 - EX-10.8 - Astria Therapeutics, Inc. | a2224803zex-10_8.htm |
| EX-10.9 - EX-10.9 - Astria Therapeutics, Inc. | a2224803zex-10_9.htm |
| EX-10.22 - EX-10.22 - Astria Therapeutics, Inc. | a2224803zex-10_22.htm |
| EX-10.23 - EX-10.23 - Astria Therapeutics, Inc. | a2224803zex-10_23.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated March 5, 2015 in Amendment No. 1 to the Registration Statement (Form S-1) and related Prospectus of Catabasis Pharmaceuticals, Inc. dated June 2, 2015.
| /s/ Ernst & Young LLP | ||
Boston, Massachusetts June 2, 2015 |
Consent of Independent Registered Public Accounting Firm